Nippon India Pharma Fund
Monthly portfolio · 24 months through Aug-2026
compared to Jul-2026 · as on August 31,2026
Holdings
36
Scheme AUM
₹9,479 cr
New
1
Exited
0
Increased
6
Reduced
5
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| Reduced | Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 59,06,349 | -3,00,000 | 12.37% | -0.94pp | ₹1,172 cr |
| Reduced | Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 7,00,754 | -50,000 | 7.00% | +0.48pp | ₹663 cr |
| — | Lupin Limited INE326A01037 | Pharmaceuticals & Biotechnology | 27,83,991 | — | 6.43% | -0.82pp | ₹609 cr |
| Increased | Cipla Limited INE059A01026 | Pharmaceuticals & Biotechnology | 40,95,054 | +3,00,000 | 6.09% | +0.06pp | ₹577 cr |
| — | Apollo Hospitals Enterprise Limited INE437A01024 | Healthcare Services | 5,48,795 | — | 5.15% | -0.15pp | ₹488 cr |
| — | Dr. Reddy's Laboratories Limited INE089A01031 | Pharmaceuticals & Biotechnology | 40,49,746 | — | 4.93% | -0.08pp | ₹468 cr |
| Increased | Mankind Pharma Limited INE634S01028 | Pharmaceuticals & Biotechnology | 16,03,562 | +1,99,133 | 4.09% | +0.35pp | ₹388 cr |
| — | Sai Life Sciences Limited INE570L01029 | Pharmaceuticals & Biotechnology | 25,55,745 | — | 3.94% | +0.32pp | ₹373 cr |
| — | Ajanta Pharma Limited INE031B01049 | Pharmaceuticals & Biotechnology | 9,13,918 | — | 3.47% | +0.06pp | ₹329 cr |
| Increased | GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | Pharmaceuticals & Biotechnology | 10,29,460 | +1,00,619 | 3.31% | +0.65pp | ₹314 cr |
| — | Max Healthcare Institute Limited INE027H01010 | Healthcare Services | 26,58,082 | — | 2.92% | -0.23pp | ₹277 cr |
| — | IPCA Laboratories Limited INE571A01038 | Pharmaceuticals & Biotechnology | 13,64,742 | — | 2.84% | +0.27pp | ₹270 cr |
| — | Vijaya Diagnostic Centre Limited INE043W01024 | Healthcare Services | 16,71,618 | — | 2.68% | +0.26pp | ₹254 cr |
| — | MedPlus Health Services Limited INE804L01022 | Retailing | 35,45,229 | — | 2.51% | -0.18pp | ₹238 cr |
| Reduced | Thyrocare Technologies Limited INE594H01019 | Healthcare Services | 38,37,967 | -1,78,660 | 2.45% | -0.06pp | ₹232 cr |
| — | Gland Pharma Limited INE068V01023 | Pharmaceuticals & Biotechnology | 8,00,549 | — | 2.44% | +0.28pp | ₹231 cr |
| — | Piramal Pharma Limited INE0DK501011 | Pharmaceuticals & Biotechnology | 99,37,272 | — | 2.25% | +0.16pp | ₹213 cr |
| Increased | Abbott India Limited INE358A01014 | Pharmaceuticals & Biotechnology | 78,126 | +3,324 | 2.13% | -0.11pp | ₹202 cr |
| — | Dr. Lal Path Labs Limited INE600L01024 | Healthcare Services | 10,00,578 | — | 2.04% | -0.01pp | ₹194 cr |
| — | Alkem Laboratories Limited INE540L01014 | Pharmaceuticals & Biotechnology | 3,23,678 | — | 1.82% | -0.19pp | ₹173 cr |
| — | Narayana Hrudayalaya Limited INE410P01011 | Healthcare Services | 8,23,911 | — | 1.66% | -0.14pp | ₹157 cr |
| — | Aurobindo Pharma Limited INE406A01037 | Pharmaceuticals & Biotechnology | 9,02,630 | — | 1.63% | +0.09pp | ₹155 cr |
| — | Pfizer Limited INE182A01018 | Pharmaceuticals & Biotechnology | 3,18,249 | — | 1.57% | -0.08pp | ₹149 cr |
| — | Syngene International Limited INE398R01022 | Healthcare Services | 35,01,497 | — | 1.48% | +0.02pp | ₹140 cr |
| — | Suraksha Diagnostic Limited INE877V01027 | Healthcare Services | 38,96,349 | — | 1.39% | +0.33pp | ₹132 cr |
| — | Fortis Healthcare Limited INE061F01013 | Healthcare Services | 13,46,128 | — | 1.29% | -0.08pp | ₹122 cr |
| Reduced | Emcure Pharmaceuticals Limited INE168P01015 | Pharmaceuticals & Biotechnology | 6,40,910 | -1,05,427 | 1.25% | -0.33pp | ₹119 cr |
| Increased | Anthem Biosciences Limited INE0CZ201020 | Pharmaceuticals & Biotechnology | 12,75,040 | +2,16,537 | 1.20% | +0.28pp | ₹114 cr |
| Reduced | Akums Drugs and Pharmaceuticals Limited INE09XN01023 | Pharmaceuticals & Biotechnology | 13,51,672 | -53,611 | 1.11% | +0.11pp | ₹105 cr |
| Increased | Biocon Limited INE376G01013 | Pharmaceuticals & Biotechnology | 25,04,071 | +5,00,000 | 1.09% | +0.17pp | ₹103 cr |
| — | Sanofi India Limited INE058A01010 | Pharmaceuticals & Biotechnology | 3,00,272 | — | 0.99% | -0.08pp | ₹93.81 cr |
| — | Sanofi Consumer Healthcare India Limited INE0UOS01011 | Pharmaceuticals & Biotechnology | 2,13,659 | — | 0.93% | -0.13pp | ₹88.46 cr |
| — | Indoco Remedies Limited INE873D01024 | Pharmaceuticals & Biotechnology | 18,34,924 | — | 0.47% | +0.04pp | ₹44.65 cr |
| — | AstraZeneca Pharma India Limited INE203A01020 | Pharmaceuticals & Biotechnology | 62,568 | — | 0.46% | -0.09pp | ₹43.49 cr |
| New | Molbio Diagnostics Limited INE869T01028 | Healthcare Equipment & Supplies | 3,80,293 | — | 0.44% | — | ₹41.31 cr |
| — | Concord Biotech Limited INE338H01029 | Pharmaceuticals & Biotechnology | 1,11,738 | — | 0.17% | — | ₹16.16 cr |
Cash & other
| Triparty Repo | 2.14% | ₹203 cr |
| Cash Margin - CCIL | 0.01% | ₹1.21 cr |
| Net Current Assets | -0.14% | ₹-14.06 cr |